1. Home
  2. TWST vs DYN Comparison

TWST vs DYN Comparison

Compare TWST & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$57.51

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$17.45

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWST
DYN
Founded
2013
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
TWST
DYN
Price
$57.51
$17.45
Analyst Decision
Buy
Strong Buy
Analyst Count
8
14
Target Price
$46.88
$37.00
AVG Volume (30 Days)
1.3M
1.6M
Earning Date
05-04-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
63.89
N/A
EPS
N/A
N/A
Revenue
$376,572,000.00
N/A
Revenue This Year
$18.91
N/A
Revenue Next Year
$15.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
20.32
N/A
52 Week Low
$23.30
$8.25
52 Week High
$66.06
$25.00

Technical Indicators

Market Signals
Indicator
TWST
DYN
Relative Strength Index (RSI) 52.71 42.74
Support Level $41.85 $16.47
Resistance Level $57.88 $19.65
Average True Range (ATR) 3.41 0.86
MACD -0.62 -0.26
Stochastic Oscillator 14.35 7.01

Price Performance

Historical Comparison
TWST
DYN

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: